Related Experiment Videos
Acinetobacter baumannii at a tertiary-care teaching hospital in Jerusalem, Israel
A Simhon1, G Rahav, G Shazberg
1Department of Clinical Microbiology & Infectious Diseases, Hadassah-University Hospital, Jerusalem, Israel. simhon@hadassah.org.il
Journal of Clinical Microbiology
|January 4, 2001
Abstract:
In a retrospective 10-year analysis of 3,536 patient-unique isolates, Acinetobacter baumannii imipenem susceptibility declined from 98.1 (1990) to 64.1% (2000), and ciprofloxacin susceptibility decreased from 50.5 to 13.1%. Imipenem median zone diameters decreased from 27. 7 (1997) to 18.8 mm (2000). No outbreaks were detected. Two clusters were identified for 41 strains genotyped by pulsed-field gel electrophoresis, but imipenem resistance was not clonal.